|
Title
|
Published
|
Price
|
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
By: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
|
more...
|
10/29/2009
|
$3,500.00
|
|
The Future of White Biotechnology in China
By: CCM International Limited
The future of white Biotechnology is attractive in China, and considerable progress in white biotechnology has been made in recent years. China’s production of many vitamins and polysaccharides products is now in a leading position
|
more...
|
9/2/2009
|
$12,150.00
|
|
Freedonia Focus on World Enzymes
By: Freedonia Focus
This report discusses world enzymes for the years 2003 and 2008, with forecasts for 2013. Topics covered include demand by type and market; production trends; regional demand overview; supply and demand in North America,
|
more...
|
8/31/2009
|
$750.00
|
|
Freedonia Focus on Enzymes
By: Freedonia Focus
This report discusses US enzyme demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, trade, technologies, environmental and regulatory considerations, market environment, product
|
more...
|
8/31/2009
|
$500.00
|
|
World Enzymes
By: Freedonia Group Inc
Enzyme demand worldwide to reach $7 billion in 2013 The world market for enzymes will recover from a difficult 2009 to reach $7 billion in 2013. Continued strong demand for specialty enzymes, as well as
|
more...
|
8/1/2009
|
$5,800.00
|
|
Small Molecule Kinase Inhibitors
By: Global Industry Analysts
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. Annual forecasts are provided for the
|
more...
|
7/1/2009
|
$3,950.00
|
|
Competitor Analysis: Aurora Kinase Inhibitors
By: La Merie S.L.
The present Competitive Intelligence Report about Aurora Kinase Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting aurora kinase for treatment of cancer as of June 2009.
Mitosis, a central
|
more...
Search inside this report
|
6/1/2009
|
$250.00
|
|
World Markets for Fermentation Ingredients
By: BCC Research
This Report States:
The global market for fermentation products is expected to increase from $15.9 billion in 2008 to $22.4 billion by the end of 2013, a compound annual growth rate (CAGR) of 7.0%.
|
more...
Search inside this report
|
6/1/2009
|
$4,850.00
|
|
Competitor Analysis: Novel Mitotic Kinase Inhibitors
By: La Merie S.L.
The present Competitive Intelligence Report about Novel Mitotic Kinase Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting polo-like kinase 1 (Plk-1), cyclin-dependent kinase (CDK) or aurora kinase for treatment of cancer
|
more...
Search inside this report
|
6/1/2009
|
$500.00
|
|
Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
By: Business Insights
Kinases are a ubiquitous group of enzymes that catalyze the phosphoryl transfer reaction from a phosphate donor (usually ATP) to a receptor substrate, which can be protein, lipid, or a small molecule (e.g. sugar). Phosphorylation
|
more...
Search inside this report
|
5/1/2009
|
$3,835.00
|
|
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2009
By: BioSeeker Group AB
Executive Summary
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful drugs are just the top
|
more...
|
1/20/2009
|
$2,099.00
|
|
Analytical Tool - Protein Kinase Inhibitors in Oncology
By: BioSeeker Group AB
Executive Summary
"Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs)
|
more...
|
1/20/2009
|
$4,340.00
|
|
The 2009 Report on Specialty Enzymes: World Market Segmentation by City
By: Icon Group International, Inc.
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets,
|
more...
Search inside this report
|
1/5/2009
|
$795.00
|
|
Competitor Analysis: Protein Kinase C (PKC) Inhibitors
By: La Merie S.L.
The present Competitive Intelligence Report about new developments in the pipeline of inhibitors of the protein kinase C (PKC) provides a competitor evaluation in the field of R&D projects from preclinical stages
|
more...
Search inside this report
|
1/2/2009
|
$275.00
|
|
Competitor Analysis: Janus Kinase (JAK) Inhibitors
By: La Merie S.L.
The present Competitive Intelligence Report about new developments in the pipeline of inhibitors of the janus-associated kinase (JAK) provides a competitor evaluation in the field of R&D projects from preclinical stages up to advanced clinical
|
more...
Search inside this report
|
12/4/2008
|
$275.00
|
|
The 2009-2014 Outlook for Specialty Enzymes in India
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for specialty enzymes across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Specialty Enzymes in the United States
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for specialty enzymes across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Specialty Enzymes in Japan
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for specialty enzymes across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Specialty Enzymes in Greater China
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for specialty enzymes across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin),
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
Competitor Analysis: Enzyme Replacement Therapies
By: La Merie S.L.
The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of December 2008 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement
|
more...
Search inside this report
|
12/1/2008
|
$345.00
|
|
Industrial Enzymes
By: Global Industry Analysts
This report analyzes the worldwide markets for Industrial Enzymes in Million of US$. The major Product segments analyzed are Carbohydrases, Proteases, Lipases, and Others. The major End use segments discussed are Food & Feed, Detergents,
|
more...
|
10/1/2008
|
$3,950.00
|
|
The 2009-2014 World Outlook for Specialty Enzymes
By: Icon Group International, Inc.
This econometric study covers the world outlook for specialty enzymes across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in
|
more...
Search inside this report
|
9/20/2008
|
$795.00
|
|
Chinese Markets for Enzymes
By: Asia Market Information & Development Company
China's demand for Enzymes has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment
|
more...
Search inside this report
|
7/1/2008
|
$4,000.00
|
|
Cancer Personalized Medicine 2008
By: Select Biosciences Limited
This is the latest most up-to-date Cancer Personalized Medicine Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Cancer Personalized Medicine Marketplace based upon Select Biosciences continuing industry coverage.
|
more...
|
7/1/2008
|
$4,860.00
|
|
Enzymes
By: Freedonia Group Inc
US demand to grow 6% annually through 2012
US demand for enzymes will rise nearly six percent per year to $2.5 billion in 2012. Advances will be led by continued rapid expansion in the fuel
|
more...
|
6/1/2008
|
$4,600.00
|
|
Title
|
Published
|
Price
|
(0 items)
